bazinaprine bazinaprine bazinaprine (sr-95,191) is an experimental drug candidate. it is a monoamine oxidase inhibitor (maoi) which is believed to be useful for the treatment of depression. the drug strongly inhibits type a monoamine oxidase, but only weakly inhibits type b. the effects of the drug are reversible in vivo, but not in vitro. in studies, the chemical has been shown to not interact in vivo with other neurotransmitter or drug receptor sites. bazinaprineclinical dataatc codenoneidentifiers iupac name 3--6-phenylpyridazine-4-carbonitrile cas number94011-82-2 npubchem cid72119chemspider65096 yuniinu8y4c529jchemblchembl150365 ycomptox dashboard (epa)dtxsid70240219 chemical and physical dataformulac17h19n5omolar mass309.373 g·mol−13d model (jsmol)interactive image smiles n#cc2cc(nnc2nccn1ccocc1)c3ccccc3 inchi inchi=1s/c17h19n5o/c18-13-15-12-16(14-4-2-1-3-5-14)20-21-17(15)19-6-7-22-8-10-23-11-9-22/h1-5,12h,6-11h2,(h,19,21) ykey:krndiphojlihri-uhfffaoysa-n y ny (what is this?) (verify)